The pleckstrin homology domain of the Wiskott-Aldrich syndrome protein is involved in the organization of actin cytoskeleton

Clinical Immunology

Volumn 92, Issue 2, 1999, Pages 128-137

  Imai, Kohsuke ^a   Nonoyama, Shigeaki ^a   Miki, Hiroaki ^b   Morio, Tomohiro ^a   Fukami, Kiyoko ^b   Zhu, Qili ^c   Aruffo, Alejandro ^d   Ochs, Hans D ^c   Yata, Jun Ichi ^a   Takenawa, Tadaomi ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

Author keywords

Actin; Cytoskeleton; Immunodeficiency; Phosphatidylinositol 4,5 bisphosphate (PIP2); Wiskott Aldrich syndrome

Indexed keywords

ACTIN; PLECKSTRIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CYTOSKELETON; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MISSENSE MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE HOMOLOGY; WISKOTT ALDRICH SYNDROME; X CHROMOSOME LINKAGE;

EID: 0032791313     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.1999.4746     Document Type: Article

References (43)

1. Sullivan K. E., Mullen C. A., Blaese R. M., Winkelstein J. A. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J. Pediatr. 125:1994;876-885.
2. Derry J. M., Ochs H. D., Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell. 78:1994;635-644.
3. Kwan S. P., Hagemann T. L., Radtke B. E., Blaese R. M., Rosen F. S. Identification of mutations in the Wiskott-Aldrich syndrome gene and characterization of a polymorphic dinucleotide repeat at DXS6940, adjacent to the disease gene. Proc. Natl. Acad. Sci. USA. 92:1995;4706-4710.
4. Weiden P. L., Blaese R. M. Hereditary thrombocytopenia: Relation to Wiskott-Aldrich syndrome with special reference to splenectomy. Report of a family and review of the literature. J. Pediatr. 80:1972;226-234.
5. Grottum K. A., Hovig T., Holmsen H., Abrahamsen A. F., Jeremic M., Seip M. Wiskott-Aldrich syndrome: Qualitative platelet defects and short platelet survival. Br. J. Haematol. 17:1969;373-388.
6. Ochs H. D., Slichter S. J., Harker L. A., Von Behrens W. E., Clark R. A., Wedgwood R. J. The Wiskott-Aldrich syndrome: Studies of lymphocytes, granulocytes, and platelets. Blood. 55:1980;243-252.
7. Molina I. J., Kenney D. M., Rosen F. S., Remold O. D. E. T cell lines characterize events in the pathogenesis of the Wiskott-Aldrich syndrome. J. Exp. Med. 176:1992;867-874.
8. Kenney D., Cairns L., Remold O. D. E., Peterson J., Rosen F. S., Parkman R. Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome. Blood. 68:1986;1329-1332.
9. Remold O. D. E., Rosen F. S., Kenney D. M. Defects in Wiskott-Aldrich syndrome blood cells. Blood. 87:1996;2621-2631.
10. Rivero-Lezcano O. M., Marcilla A., Sameshima J. H., Robbins K. C. Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains. Mol. Cell. Biol. 15:1995;5725-5731.
11. Banin S., Truong O., Katz D. R., Waterfield M. D., Brickell P. M., Gout I. Wiskott-Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases. Curr. Biol. 6:1996;981-988.
12. Bunnell S. C., Henry P. A., Kolluri R., Kirchhausen T., Rickles R. J., Berg L. J. Identification of Itk/Tsk Src homology 3 domain ligands. J. Biol. Chem. 271:1996;25646-25656.
13. Finan P. M., Soames C. J., Wilson L., Nelson D. L., Stewart D. M., Truong O., Hsuan J. J., Kellie S. Identification of regions of the Wiskott-Aldrich syndrome protein responsible for association with selected Src homology 3 domains. J. Biol. Chem. 271:1996;26291-26295.
14. Cory G. O., MacCarthy-Morrogh L., Banin S., Gout I., Brickell P. M., Levinsky R. J., Kinnon C., Lovering R. C. Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. J. Immunol. 157:1996;3791-3795.
15. Symons M., Derry J. M., Karlak B., Jiang S., Lemahieu V., McCormick F., Francke U., Abo A. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell. 84:1996;723-734.
16. Aspenstrom P., Lindberg U., Hall A. Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott-Aldrich syndrome. Curr. Biol. 6:1996;70-75.
17. Kolluri R., Tolias K. F., Carpenter C. L., Rosen F. S., Kirchhausen T. Direct interaction of the Wiskott-Aldrich syndrome protein with the GTPase Cdc42. Proc. Natl. Acad. Sci. USA. 93:1996;5615-5618.
18. Miki H., Miura K., Takenawa T. N-WASP, a novel actin-depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2-dependent manner downstream of tyrosine kinases. EMBO J. 15:1996;5326-5335.
19. Schwartz M., Bekassy A., Donner M., Hertel T., Hreidarson S., Kerndrup G., Stormorken H., Stokland T., Tranebjaerg L., Orstavik K. H., Skovby F. Mutation spectrum in patients with Wiskott-Aldrich syndrome and X-linked thrombocytopenia: Identification of twelve different mutations in the WASP gene. Thromb. Haemost. 75:1996;546-550.
20. Zhu Q., Zhang M., Blaese R. M., Derry J. M., Junker A., Francke U., Chen S. H., Ochs H. D. The Wiskott-Aldrich syndrome and X-linked congenital thrombocytopenia are caused by mutations of the same gene. Blood. 86:1995;3797-3804.
21. Fukami K., Matsuoka K., Nakanishi O., Yamakawa A., Kawai S., Takenawa T. Antibody to phosphatidylinositol 4,5-bisphosphate inhibits oncogene-induced mitogenesis. Proc. Natl. Acad. Sci. USA. 85:1988;9057-9061.
22. Zhu Q., Watanabe C., Liu T., Hollenbaugh D., Blaese R. M., Kanner S. B., Aruffo A., Ochs H. D. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype. Blood. 90:1997;2680-2689.
23. Villa A., Notarangelo L., Macchi P., Mantuano E., Cavagni G., Brugnoni D., Strina D., Patrosso M. C., Ramenghi U., Sacco M. G. X-linked thrombocytopenia and Wiskott-Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat. Genet. 9:1995;414-417.
24. Kolluri R., Shehabeldin A., Peacocke M., Lamhonwah A. M., Teichert-Kuliszewska K., Weissman S. M., Siminovitch K. A. Identification of WASP mutations in patients with Wiskott-Aldrich syndrome and isolated thrombocytopenia reveals allelic heterogeneity at the WAS locus. Hum. Mol. Genet. 4:1995;1119-1126.
25. Schindelhauer D., Weiss M., Hellebrand H., Golla A., Hergersberg M., Seger R., Belohradsky B. H., Meindl A. Wiskott-Aldrich syndrome: No strict genotype-phenotype correlations but clustering of missense mutations in the amino-terminal part of the WASP gene product. Hum. Genet. 98:1996;68-76.
26. de Saint Basile G., Lagelouse R. D., Lambert N., Schwarz K., Le Mareck B., Odent S., Schlegel N., Fischer A. Isolated X-linked thrombocytopenia in two unrelated families is associated with point mutations in the Wiskott-Aldrich syndrome protein gene. J. Pediatr. 129:1996;56-62.
27. Wengler G. S., Notarangelo L. D., Berardelli S., Pollonni G., Mella P., Fasth A., Ugazio A. G., Parolini O. High prevalence of nonsense, frame shift, and splice-site mutations in 16 patients with full-blown Wiskott-Aldrich syndrome. Blood. 86:1995;3648-3654.
28. Wengler G. S., Notarangelo L. D., Giliani S., Pirastru M. G., Ugazio A. G., Parolini O. Mutation analysis in Wiskott-Aldrich syndrome on chorionic villus DNA [letter]. Lancet. 346:1995;641-642.
29. Kwan S. P., Hagemann T. L., Blaese R. M., Knutsen A., Rosen F. S. Scanning of the Wiskott-Aldrich syndrome (WAS) gene: Identification of 18 novel alterations including a possible mutation hotspot at Arg86 resulting in thrombocytopenia, a mild WAS phenotype. Hum. Mol. Genet. 4:1995;1995-1998.
30. Derry J. M., Kerns J. A., Weinberg K. I., Ochs H. D., Volpini V., Estivill X., Walker A. P., Francke U. WASP gene mutations in Wiskott-Aldrich syndrome and X-linked thrombocytopenia. Hum. Mol. Genet. 4:1995;1127-1135.
31. Harlan J. E., Hajduk P. J., Yoon H. S., Fesik S. W. Pleckstrin homology domains bind to phosphatidylinositol-4,5-bisphosphate. Nature. 371:1994;168-170.
32. Harlan J. E., Yoon H. S., Hajduk P. J., Fesik S. W. Structural characterization of the interaction between a pleckstrin homology domain and phosphatidylinositol 4,5-bisphosphate. Biochemistry. 34:1995;9859-9864.
33. Lemmon M. A., Ferguson K. M., O'Brien R., Sigler P. B., Schlessinger J. Specific and high-affinity binding of inositol phosphates to an isolated pleckstrin homology domain. Proc. Natl. Acad. Sci. USA. 92:1995;10472-10476.
34. Garcia P., Gupta R., Shah S., Morris A. J., Rudge S. A., Scarlata S., Petrova V., McLaughlin S., Rebecchi M. J. The pleckstrin homology domain of phospholipase C-delta 1 binds with high affinity to phosphatidylinositol 4,5-bisphosphate in bilayer membranes. Biochemistry. 34:1995;16228-16234.
35. Lemmon M. A., Ferguson K. M., Schlessinger J. PH domains: Diverse sequences with a common fold recruit signaling molecules to the cell surface. Cell. 85:1996;621-624.
36. Ferguson K. M., Lemmon M. A., Schlessinger J., Sigler P. B. Structure of the high affinity complex of inositol trisphos-phate with a phospholipase C pleckstrin homology domain. Cell. 83:1995;1037-1046.
37. Saraste M., Hyvonen M. Pleckstrin homology domains: A fact file. Curr. Opin. Struct. Biol. 5:1995;403-408.
38. Yao L., Kawakami Y., Kawakami T. The pleckstrin homology domain of Bruton tyrosine kinase interacts with protein kinase C. Proc. Natl. Acad. Sci. USA. 91:1994;9175-9179.
39. Touhara K., Inglese J., Pitcher J. A., Shaw G., Lefkowitz R. J. Binding of G protein beta gamma-subunits to pleckstrin homology domains. J. Biol. Chem. 269:1994;10217-10220.
40. Salim K., Bottomley M. J., Querfurth E., Zvelebil M. J., Gout I., Scaife R., Margolis R. L., Gigg R., Smith C. I., Driscoll P. C., Waterfield M. D., Panayotou G. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J. 15:1996;6241-6250.
41. Stossel T. P. On the crawling of animal cells. Science. 260:1993;1086-1094.
42. Falasca M., Logan S. K., Lehto V. P., Baccante G., Lemmon M. A., Schlessinger J. Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting. EMBO J. 17:1998;414-422.
43. August A., Sadra A., Dupont B., Hanafusa H. Src-induced activation of inducible T cell kinase (ITK) requires phosphatidylinositol 3-kinase activity and the Pleckstrin homology domain of inducible T cell kinase. Proc. Natl. Acad. Sci. USA. 94:1997;11227-11232.